Clinical Trials
- Arthritis
Yale Rheumatology Program Patient Registry and Bio-Repository
- Ages18 years - 99 years
- GenderBoth
- Diabetes
Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab (PROTECT)
- Ages8 years - 17 years
- GenderBoth
- Immune System
Inhibition of Sterile Inflammation by Digoxin
- Ages18 years - 70 years
- GenderBoth